Ken Griffin Calliditas Therapeutics Ab Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Citadel Advisors LLC holds 8,500 shares of CALT stock, worth $340,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,500
Previous 1,500
466.67%
Holding current value
$340,000
Previous $31,000
967.74%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CALT
# of Institutions
22Shares Held
827KCall Options Held
8.5KPut Options Held
26.6K-
Bvf Inc San Francisco, CA750KShares$30 Million0.89% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.6KShares$1.03 Million0.56% of portfolio
-
Optiver Holding B.V. Amsterdam, P722.3KShares$893,4400.02% of portfolio
-
Ubs Group Ag10.8KShares$430,2400.0% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16KShares$240,0000.2% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.06B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...